Picard Medical, Inc. (PMI) Operating Margin
- Operating margin · 12 months: Value -248.10%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -248.10% | Operating income / revenue. Period ending 2026-06-30. $-15.63M ÷ $6.30M × 100 ≈ -248.10% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -15.63M USD | Operating Income (Loss) |
| Revenue | 6.30M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
| Research and development | 4.77M USD | Research and Development Expense |
| Selling, general and administration | 12.04M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-15.63M | $6.30M | (m) | $4.77M | $12.04M | -248.10% |
| 2026-03-31 | $-14.52M | $5.47M | (m) | $4.14M | $10.81M | -265.48% |
| 2025-12-31 | $-13.26M | $4.94M | (m) | $3.05M | $10.00M | -268.36% |
| 2025-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $-13.71M | $4.39M | (m) | $3.38M | $10.22M | -312.28% |
| 2024-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |